Nuchal translucency in first trimester of pregnancy: a descriptive study

Anshumala Joshi; Om Biju Panta; Riwaz Acharya; Astha Shrestha

doi:10.18203/2320-1770.ijrcog20254257

Authors

Anshumala Joshi Department of Obstetrics and Gynecology, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal
Om Biju Panta Department of Radiology, Nepal Medicity Hospital, Kathmandu, Nepal
Riwaz Acharya Department of Radiology, Nepal Medical College, Kathmandu, Nepal
Astha Shrestha Department of Obstetrics and Gynecology, Nepal Medical College and Teaching Hospital, Kathmandu,

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20254257

Abstract

Background: American college of obstetricians and gynecologists’ (ACOG) committee recommends all women should be offered aneuploidy screening before 20 weeks of gestation. Nuchal translucency (NT) measurement is currently a routine first trimester ultrasound. There is a void in studies of NT measurement in the Nepali population. The objective of the study was to determine the normal value of NT in the Nepalese population.

Methods: This was a hospital based descriptive study done in the obstetrics and gynecology department in Nepal medical college and teaching hospital, Jorpati, for one year. All pregnant women attending the antenatal care clinic before 11 weeks of gestation with a singleton live fetus, within the study period were considered for the study. The fetal NT at 11-13 weeks was measured.

Results: A total of 305 women participated in the study. Twenty-one women were excluded for various reasons, and a total of 284 women were included. The median age of the women was 26 years (IQR, 23-30 years), with a minimum age of 16 years and a maximum age of 41 years. The mean NT was 1.27±0.30 mm with a minimum of 0.6 mm and a maximum of 2.7 mm. There were two women with raised NT. The median Crown Rump length (CRL) was 65 mm (IQR, 54.8-68.3 mm). The minimum CRL was 45 mm and maximum was 79 mm. There was a weak positive correlation of NT with CRL with r=0.15 and p=0.013. The NT of male fetuses was slightly higher as compared to female fetuses (1.30±0.34 mm Vs 1.22±0.24 mm).

Conclusions: The normal value of NT in Nepalese population is within 3 mm. There was a weak positive correlation of NT with CRL.

References

Bestwick JP, Huttly WJ, Wald NJ. Distribution of nuchal translucency in antenatal screening for Down’s syndrome. Med Screen. 2010;17(1):8-12.

Al-Biltagi M. Down syndrome from Epidemiological Point of View. EC Paediatrics. 2015;2(1):82-91.

Muller F, Benattar C, Audibert F, Roussel N, Dreux S and Cuckle H. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers. Prenat Diagn. 2003;23(10):833-6.

Blumenfeld Y. First Trimester Screening for Fetal Aneuploidy. NeoReviews. 2012;13(1):e4-8.

Nicolaides KH, Heath V, Cicero S. Increased fetal nuchal translucency at 11-14 weeks. Prenal Diagn 2002;22(4);308-15.

Sharifzadeh M, Adibi A, Kazemi K, Hovsepian S. Normal reference range of fetal nuchal translucency thickness in pregnant women in the first trimester, one center study. J Res Med Sci. 2015;20(10):969-73.

Smith DA. First-Trimester Nuchal Translucency Screening to Detect Down Syndrome. Newborn Infant Nurs Rev. 2008;8(1):e1-6.

American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020;136(4):e48-69.

Dinc G, Eyuboglu I. Distribution of nuchal translucency thickness at 11 to 14 weeks of gestation in a normal Turkish Population. Turk J Med Sci. 2021;51:90-4.

Kor-anantakul O, Suntharasaj T, Suwanrath C, Chanprapaph P, Sirichotiyakul S, Ratanasiri T, et al. Distribution of Normal Nuchal Translucency Thickness: A Multicenter Study in Thailand. Gynecol Obstet Invest. 2011;71(2):124-8.

Jou HJ, Wu SC, Li TC, Hsu H-C, Tzeng C-Y, Hseieh F-J. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultasound Obstet Gynecol. 2001;17(2):111-4.

Raksha M, Dhananjaya KVN, Malini KV, Baliga A. Significance of Sonological Evaluation of Nuchal Translucency and Correlation with Pregnancy Outcome. J South Asian Federation Obstet Gynaecol. 2019;11(4):225-9.

Karki S, Joshi KS, Tamrakar SR, Regmi S, Khanal K. Nuchal Translucency in Normal Fetus and its Variation with Increasing Crown Rump Length (CRL) and Gestational age. Kathmandu Univ Medical J. 2013;11(44):282-6.

Marsis O. Screening for Down syndrome Using Nuchal Translucency Thickness and Nasal Bone Examination at Advanced Maternal Age in Jakarta: A Preliminary Report. J Med Ultrasound. 2004;12(1):1-6.

Naidoo P, Erasmus I, Jeebodh J, Nicolaou E, van Gelderen CJ. Nuchal translucency as a method of first-trimester screening for aneuploidy. S Afr Med J. 2008;98(4):295-9.

Barati M, Zargar M, Masihi S, Taherpour S. Evaluation of Nuchal Translucency Measurement in First Trimester Pregnancy. Int J Fertility Sterility. 2011;5(1):35-8.

Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down’s syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen. Health Technol Assess. 2003;7(11):1-77.

Zehrer T, Stankeviciene I, Abdel-Aal M. Comparison of National Downs screening uptake, results, and outcomes to a district general hospital. Comparison of National Downs Screening Uptake, Results. The Fetal Medicine Foundation2014.

Alfirevic Z, Neilson JP. Antenatal screening for Down’s syndrome (Editorial). Brit Med J. 2004;329(7470):811-2.

Driscoll DA, Gross SJ. First trimester diagnosis and screening for fetal aneuploidy. ACMG Practice Guidelines Genet Med. 2008;10(1):73-5.